2-{[4-(5-Ethylpyrimidin-4-Yl)piperazin-1-Yl]methyl}-5-(Trifluoromethyl)-1h-Benzimidazole(CAS: 1255517-76-0)

This compound is subject to various regulatory guidelines. In the European Union, it is regulated under REACH for chemical registration, evaluation, authorization, and restriction. Globally, it must comply with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labeling. FDA and EPA regulations in the United States may also apply for specific uses. Compliance with local and regional regulations is essential.

Several alternatives exist for synthesizing similar compounds. Analogous structures like 4-(5-ethylpyrimidin-4-yl)piperazine derivatives or other 1H-benzimidazole derivatives can be used. Substitutes such as different piperazine rings or alternative fluorinated groups can provide similar functionalities with potentially different properties.

The market for this compound is currently focused on its applications in pharmaceutical research, particularly as an intermediate in the development of antiviral and antiparasitic drugs. Research trends indicate ongoing interest in optimizing synthetic methods and exploring its biological properties in clinical trials.

Waste containing this compound should be collected in appropriate chemical waste containers and disposed of through professional waste disposal services. Incineration is a common method, with proper control of emissions. Environmental protection guidelines must be followed to prevent contamination of soil and water. Consult local regulations for specific disposal procedures.